1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cholera Infantum in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, M; Dombrowsky, H; Frerichs, I; Goldmann, T; Lautenschläger, I; Sarau, J; Uhlig, S; Weiler, N; Zitta, K | 1 |
Jewell, DP; Travis, SP | 1 |
Fletcher, JR | 1 |
Giudice, A; Herbert, JM; Le Fur, G; Maffrand, JP; Manara, L; Manzoni, L | 1 |
Hawkey, CJ; Stack, WA | 1 |
Andersson, R; Börjesson, A; Sun, Z; Wang, X | 1 |
Benveniste, J; Denizot, Y; Lewin, MJ; Mignon, M; Sobhani, I; Vatier, J; Vissuzaine, C | 1 |
Hsueh, W; Sun, XM; Torre-Amione, G | 1 |
MacNaughton, WK; Wallace, JL | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholera Infantum
Article | Year |
---|---|
The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
Topics: Adjuvants, Immunologic; Animals; Cholestasis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Digestive System Physiological Phenomena; Enterocolitis, Pseudomembranous; Epithelium; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypertension, Portal; Ischemia; Microcirculation; Pancreatitis; Peptic Ulcer; Platelet Activating Factor | 1994 |
Eicosanoids. Critical agents in the physiological process and cellular injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Eicosanoids; Gastrointestinal Diseases; General Surgery; Humans; Lipoxygenase; Molecular Biology; Phospholipids; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Tumor Necrosis Factor-alpha | 1993 |
Specific mediator-directed therapy for gastrointestinal diseases.
Topics: Animals; Antibodies; Cyclosporine; Cytokines; Gastrointestinal Diseases; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Leukotriene Antagonists; Lipoxygenase Inhibitors; Mice; Mice, Knockout; Oligonucleotides, Antisense; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Thromboxanes; Tumor Necrosis Factor-alpha | 1997 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholera Infantum
Article | Year |
---|---|
Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.
Topics: Animals; Dexamethasone; Disease Models, Animal; Edema; Eicosanoids; Female; Gastrointestinal Diseases; Intestinal Mucosa; Paralysis; Platelet Activating Factor; Protective Agents; Quinidine; Rats; Vasoconstriction | 2015 |
Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine.
Topics: Animals; Azepines; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Diseases; Intestinal Mucosa; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Thiazoles; Triazoles | 1996 |
Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Topics: Animals; Capillaries; Endothelium, Vascular; Gastrointestinal Diseases; Imidazoles; Intercellular Adhesion Molecule-1; Interleukins; Leucine; Leukocytes; Lymphocyte Activation; Male; Pancreatitis; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley | 1999 |
Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man.
Topics: Adult; Clinical Enzyme Tests; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Middle Aged; Pentagastrin; Platelet Activating Factor; Regression Analysis; Secretin; Urease | 1992 |
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |
Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
Topics: Animals; Dexamethasone; Gastrointestinal Diseases; Hemodynamics; Leukotriene B4; Male; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Stomach Ulcer | 1988 |